Avantor, Inc. (NYSE:AVTR) Stock Position Raised by National Pension Service

National Pension Service boosted its position in shares of Avantor, Inc. (NYSE:AVTR) by 5.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,288,319 shares of the company’s stock after purchasing an additional 69,818 shares during the period. National Pension Service owned 0.19% of Avantor worth $33,329,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AVTR. 1832 Asset Management L.P. boosted its position in shares of Avantor by 1,634.9% in the second quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company’s stock worth $180,839,000 after buying an additional 8,038,451 shares during the period. CCLA Investment Management boosted its position in Avantor by 147,220.3% during the 1st quarter. CCLA Investment Management now owns 4,720,144 shares of the company’s stock worth $120,828,000 after acquiring an additional 4,716,940 shares during the period. Sound Shore Management Inc. CT purchased a new position in Avantor during the 2nd quarter valued at about $76,412,000. Canada Pension Plan Investment Board grew its stake in Avantor by 6.8% during the 2nd quarter. Canada Pension Plan Investment Board now owns 22,927,325 shares of the company’s stock valued at $486,059,000 after acquiring an additional 1,463,695 shares in the last quarter. Finally, Magnetar Financial LLC acquired a new position in shares of Avantor in the 1st quarter valued at about $35,154,000. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the business’s stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the transaction, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at $740,372.64. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is currently owned by company insiders.

Avantor Trading Up 0.9 %

NYSE:AVTR opened at $22.97 on Thursday. The company’s 50 day moving average is $25.03 and its 200-day moving average is $24.14. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. Avantor, Inc. has a 12 month low of $18.08 and a 12 month high of $28.00. The firm has a market cap of $15.63 billion, a price-to-earnings ratio of 49.93, a P/E/G ratio of 2.70 and a beta of 1.35.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. UBS Group decreased their price target on shares of Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a report on Tuesday, October 8th. Robert W. Baird decreased their target price on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Morgan Stanley boosted their price target on shares of Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a report on Monday, July 29th. TD Cowen increased their price objective on Avantor from $28.00 to $31.00 and gave the stock a “buy” rating in a report on Monday, July 29th. Finally, Citigroup downgraded Avantor from a “buy” rating to a “neutral” rating and lowered their target price for the company from $30.00 to $23.00 in a research note on Wednesday, July 10th. Three equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $27.57.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.